Prostate cancer radiation tailored to patients with hip replacements
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new radiation therapy method that uses MRI to adjust your treatment in real time. It is designed for people with bilateral hip replacements who are undergoing standard radiation for localized prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with localized prostate cancer and are planning to receive a specific type of radiation called SBRT.
- You have hip replacements on both sides, and they are labeled as safe or conditionally safe for MRI.
- You are generally well enough to carry out daily activities (ECOG score 0-2).
- You are 18 years or older and willing to sign a consent form.
- You do not have any metal implants or medical devices that are unsafe for MRI (like certain pacemakers or aneurysm clips).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a new way of giving high-dose radiation therapy to prostate cancer that has spread to nearby lymph nodes. The radiation is given weekly and uses special imaging to target the tumor precisely, which may help control the cancer while limiting side effects.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
Hear when a new Localized Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.